Influenza B viruses having alterations in the hemagglutinin polypeptide
US9068986B2 · kind B2 · utility
0Cited by
41References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 22, 2014 |
| Grant date | Jun 30, 2015 |
| Priority date | — |
| Expiry date | Jan 22, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16261
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention encompasses methods of producing influenza B viruses in cell culture. The influenza B viruses may have desirable characteristics, such as enhanced replication in eggs and may be used, for example, in vaccines and in methods of treatment to protect against influenza B virus infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.